By Michele Maatouk
Date: Wednesday 27 Mar 2024
LONDON (ShareCast) - (Sharecast News) - RBC Capital Markets cut its price target on Dr Martens on Wednesday to 85p from 100p as it lowered its estimates for FY24-26 earnings per share by 7% to 10%.
The bank said Dr Martens should be able to deliver on materially lower guided and consensus expectations for FY24, due 30 May.
The bank said Spring/Summer shipment timings could be a swing factor, however it believes Q4 DTC trends will be an important data point as well as FY25.
RBC said it expects the company's FY25 guidance to strike a "cautious tone". It expects revenue guidance of 'mid-single digit' and an EBITDA guidance range of £200m to £210m, which implies mid-high single-digit growth year-on-year.
RBC rates the shares at 'sector perform'.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 85.00p |
Change Today | 2.15p |
% Change | 2.60 % |
52 Week High | 171.20p |
52 Week Low | 67.00p |
Volume | 2,402,237 |
Shares Issued | 961.94m |
Market Cap | £817.65m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 04-Jan-24 | 08-Jun-23 |
Paid | 02-Feb-24 | 18-Jul-23 |
Amount | 1.56p | 4.28p |
Time | Volume / Share Price |
16:51 | 2,727 @ 85.00p |
16:35 | 10,000 @ 84.50p |
16:35 | 10,000 @ 84.50p |
16:35 | 116,578 @ 85.00p |
16:35 | 458,801 @ 85.00p |
You are here: research